Besides, a clinical trial has reported that IFNG maintenance therapy failed to benefit GBM patients (23), indicating that our understanding of the role of IFNG in GBM, as well as its clinical significance, remains inadequate. This evidence concerns the gene IFNG and glioblastoma.